Day One Biopharmaceuticals (DAWN) Leases (2022 - 2025)
Historic Leases for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to $2.4 million.
- Day One Biopharmaceuticals' Leases fell 481.74% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 481.74%. This contributed to the annual value of $2.4 million for FY2024, which is 58806.82% up from last year.
- Day One Biopharmaceuticals' Leases amounted to $2.4 million in Q3 2025, which was down 481.74% from $2.5 million recorded in Q2 2025.
- Over the past 5 years, Day One Biopharmaceuticals' Leases peaked at $2.6 million during Q1 2025, and registered a low of $164000.0 during Q2 2024.
- Moreover, its 4-year median value for Leases was $699000.0 (2022), whereas its average is $1.2 million.
- Its Leases has fluctuated over the past 5 years, first plummeted by 6905.66% in 2024, then soared by 142378.05% in 2025.
- Day One Biopharmaceuticals' Leases (Quarter) stood at $699000.0 in 2022, then crashed by 49.64% to $352000.0 in 2023, then skyrocketed by 588.07% to $2.4 million in 2024, then increased by 1.16% to $2.4 million in 2025.
- Its Leases stands at $2.4 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.6 million for Q1 2025.